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All reactions were carried out under an argon atmosphere in dry solvents under anhydrous 
conditions. Drying of organic extracts during workup of reactions was performed over 
anhydrous Na2SO4 except where otherwise stated. Evaporation of solvents was accomplished 
with a rotatory evaporator. Analytical thin layer chromatography was performed on SiO2 
(Merck silica gel 60 F254) or on glass-backed plates pre-coated with silica and the spots were 
located with aqueous KMnO4 or p-anisaldehyde. Chromatography refers to flash 
chromatography and was carried out on SiO2 (silica gel 60 ACC, 35-75 μm, 230-240 mesh 
ASTM). NMR spectra were recorded in CDCl3 on a Varian Mercury 400 MHz or Varian VNMRS 
400 MHz. Chemical shifts of 1H and 13C NMR spectra are reported in ppm downfield (δ) from 
Me4Si. All NMR data assignments are supported by COSY and HSQC experiments. 














To a stirring solution of cyclohexanone (1 equiv) and solid acid catalyst Amberlite IR 120 H® (5 
equiv w/w) in MeOH (0.1-0.5 M) at 50 °C, was added phenylhydrazine 1 or phenylhydrazine 
hydrochloric salt 1·HCl (1.1 equiv). The mixture was left stirring at 50 °C for the indicated time. 
After cooling, the reaction mixture was filtered and the resin was washed with CH2Cl2 and 




Following the general procedure using cyclohexanone (260 µL, 2.5 mmol) 
and phenylhydrazine 1a (270 μL, 2.75 mmol) for 1 h, 2a was isolated as a 
pale yellowish solid (415 mg, 97%) whose data proved consistent with 
the literature.1 
Mp: 115-119 C (lit.1a 119-120 C); 1H NMR (CDCl3, 400 MHz): δ 1.85-1.98 (m, 4H), 2.70-2.76 
(m, 4H), 7.06-7.16 (m, 2H), 7.28 (br d, J = 7.5 Hz, 1H), 7.48 (br d, J =7.5 Hz, 1H) 7.63 (br s, 1H); 
13C NMR (CDCl3, 100 MHz): δ 21.1, 23.36, 23.40, 23.44, 110.3, 110.4, 117.9, 119.2, 121.1, 
128.0, 134.2, 135.8 
 
6-Isopropyl-2,3,4,9-tetrahydro-1H-carbazole (2b) 
Following the general procedure using cyclohexanone (230 µL, 2.2 
mmol) and p-isopropylphenylhydrazine hydrochloride salt 1b·HCl 
(467 mg, 2.4 mmol) for 1.5 h, 2b was isolated as a pale yellowish 
solid (445 mg, 95%) whose data proved consistent with the 
literature.2 
Mp: 67-69 C (lit.2 68-70 C); 1H NMR (CDCl3, 400 MHz): δ 1.34 (d, J = 
7.0 Hz, 6 H), 1.87-1.98 (m, 4H), 2.69-2.77 (m, 4H), 3.04 (hep, J = 7.0 Hz, 1H), 7.04 (dd, J = 8.5, 
2.0 Hz, 1H), 7.20 (d, J = 8.5 Hz, 1H), 7.34 (d, J = 2.0 Hz, 1H), 7.53 (br s, 1H); 13C NMR (CDCl3, 100 
MHz): δ 21.1, 23.39, 23.40, 23.5, 24.9, 34.4, 110.0, 110.2, 114.8, 120.1, 128.0, 134.3, 134.4, 
140.0  
                                                                
1 a) Welch W. M., Synthesis, 1977, 9, 645-646 b) Sun K., Liu S., Bec P. M., and Driver T. G., Ang. Chem. Int. Ed. 2011, 50, 
1702-1706  







Following the general procedure using cyclohexanone (230 µL, 2.2 
mmol) and p-methoxyphenylhydrazine hydrochloride salt 1c·HCl 
(442 mg, 2.5 mmol) for 2 h, 2c was isolated as a pale pink solid (389 
mg, 93%) whose data proved consistent with the literature.3a 
Mp: 89-90 C (lit. 91-92 C); 1H NMR (CDCl3, 400 MHz): δ 1.83-1.95 
(m, 4H), 2.65-2.75 (m, 4H), 3.87 (s, 3H), 6.78 (dd, J = 8.5, 2.5 Hz, 1H), 6.94 (d, J = 2.5 Hz, 1H), 
7.16 (d, J = 8.5 Hz, 1H), 7.56 (br s, 1H); 13C NMR (CDCl3, 100 MHz): δ 21.1, 23.3, 23.4, 23.5, 56.1, 
100.4, 110.1, 110.6, 111.1, 128.3, 130.9, 135.2, 154.0 
 
6-Fluoro-2,3,4,9-tetrahydro-1H-carbazole (2d) 
Following the general procedure using cyclohexanone (230 µL, 2.2 
mmol) and p-fluorophenylhydrazine hydrochloride salt 1d·HCl (408 mg, 
2.5 mmol) for 2 h, 2d was isolated as a pale yellowish solid (389 mg, 
93%) whose data proved consistent with the literature.3 
Mp: 103-104 C (lit.3 106-108 C); 1H NMR (CDCl3, 400 MHz): δ 1.83-
1.96 (m, 4H), 2.64-2.74 (m, 4H), 6.85 (td, J = 9.5, 2.5 Hz, 1H), 7.10 (dd, J = 9.5, 2.5 Hz, 1H), 7.17 
(dd, J = 9.0, 4.5 Hz, 1H), 7.65 (br s, 1H); 13C NMR (CDCl3, 100 MHz): δ 21.0, 23.2, 23.3, 23.4, 
103.0 (d, J = 23.5 Hz), 108.9 (d, J = 26.0 Hz), 110.6, 110.8 (d, J = 9.5 Hz), 128.3, 132.2, 136.3, 
157.9 (d, J = 232 Hz) 
 
6-Trifluoromethyl-2,3,4,9-tetrahydro-1H-carbazole (2e) 
Following the general procedure using cyclohexanone (104 µL, 1 
mmol), p-trifluoromethylphenylhydrazine 1e (1.05 g, 6.0 mmol) and 
Amberlite IR 120 H (2.7g) for 3 h, filtration on silica with 10% EtOAc 
/hexane prior to crystallization affords 2e as brown yellow solid (220 
mg, 92%) whose data proved consistent with the literature.4 
1H NMR (CDCl3, 400 MHz): δ 1.85-1.98 (m, 4H), 2.70-2.77 (m, 4H), 7.30-7.38 (m, 2H), 7.75 (s, 
1H), 7.83 (br s, 1H); 13C NMR (CDCl3, 100 MHz): δ 20.8, 23.1, 23.2, 23.3, 110.5, 111.2, 115.5 (q, J 




                                                                
3 a) Chen  J. and Hu Y., Synth. Comm. 2006, 36, 1485 b) Sun K., Liu S., Bec P. M., and Driver T. G., Ang. Chem. Int. Ed. 2011, 
50, 1702-1706 





General procedure B: 
 
A stirring solution of phenylhydrazine (10 equiv) and solid acid catalyst Amberlite IR 120 H® (10 
equiv w/w with respect to 3) in MeOH (0.05-0.1 M) was mixed for 5 min at 70 °C. To this 
mixture was added ketone 3 (1 equiv). The mixture was left stirring at 70 °C for 24 h. After 
cooling, the reaction mixture was filtered and the resin was washed with CH2Cl2 and MeOH 
and the crude product was purified by crystallization from cold MeOH or cold CH2Cl2 to afford 




Following the general procedure B using phenylhydrazine 1a (915 μL, 
9.33 mmol), 5-oxodecahydroquinoline 3 (300 mg, 0.93 mmol) and 
Amberlite IR 120 H® (3 g) for 20 h, 4a was isolated as a pale yellow 
solid (320 mg, 88%) further crystallization from CHCl3 and 
dichloroethane afforded pale yellow crystal.  
Mp: 213-215 C; 1H NMR (COSY, CDCl3, 400 MHz):  δ 1.28-1.38 (m, 1H, 
H-5eq), 1.32 (d, J = 7.2  Hz, 3H, H-12), 1.53-1.61 (m, 2H, H-1 and H-2), 1.65-1.70 (m, 1H, H-2), 
1.92-2.01 (m, 1H, H-1), 2.31 (ddd, J = 12.8, 12.8, 6.0 Hz, 1H, H-5ax), 2.45 (s, 3H, H-17), 2.88 
(ddd, J = 10.4, 5.2, 5.2 Hz, 1H, H-11b), 2.97 (ddd, J = 12.8, 12.8, 2.8 Hz, 1H, H-3ax), 3.21 (br 
quint, J = 7.0 Hz, 1H, H-6), 3.95 ( br d, J = 13.2 Hz, 1H, H-3eq), 4.56 (ddd, J = 13.2, 5.2, 3.2 Hz, 
1H, H-4a), 7.05-7.15 (m, 2H, H-8 and H-9), 7.27 (d, J = 8.0 Hz, 1H, H-10), 7.31 (d, J = 8.0 Hz, 2H, 
H-15), 7.47 (d, J = 7.6 Hz, 1H, H-7), 7.66 (br s, 1H, H-11), 7.76 (d, J = 8.4 Hz, 2H, H-14); 13C NMR 
(100 MHz, HSQC, CDCl3): δ 21.2 (C-12), 21.5 (C-17), 24.7 (C-2), 25.8 (C-6), 27.7 (C-1), 28.4 (C-5), 
34.2 (C-11b), 40.5 (C-3), 49.1 (C-4a), 110.7 (C-10), 113.5 (C-6a), 118.3 (C-7), 119.3 (C-8), 121.5 
(C-9), 126.5 (C-6b), 127.0 (C-14), 129.7 (C-15), 135.8 (C-10a), 136.2 (C-13), 138.5 (C-16), 143.1 
(C-11a); HRMS: m/z calcd for C23H27N2O2S (M + H)




Following the general procedure B using p-
isopropylphenylhydrazine 1b (467 mg, 3.11 mmol), 5-
oxodecahydroquinoline 3 (100 mg, 0.31 mmol) and Amberlite IR 
120 H® (1.00 g) for 20 h 4b was isolated after trituration in cold 
MeOH and recrystallization in dichloroethane as a white solid 





Mp:161-163 C; 1H NMR (COSY, CDCl3, 400 MHz):  δ 1.25-1.35 (m, 1H, H-5eq), 1.30 (br d, J = 6.8 
Hz, 6H, 2 x CH3 iPr), 1.33 (d, J = 7.2  Hz, 3H, H-12), 1.52-1.59 (m, 2H, H-1 and H-2), 1.62-1.68 (m, 
1H, H-2), 1.92-1.98 (m, 1H, H-1), 2.30 (ddd, J = 13.2, 13.2, 6.4 Hz, 1H, H-5ax), 2.45 (s, 3H, H-17), 
2.85 (ddd, J = 11.6, 5.0, 5.0 Hz, 1H, H-11b), 2.91-3.05 (m, 2H, H-3ax & CH iPr), 3.20 (br quint, J = 
7.2 Hz, 1H, H-6), 3.94 (br d, J = 12.4 Hz, 1H, H-3eq), 4.56 (ddd, J = 13.2,  5.0, 3.2 Hz, 1H, H-4a), 
7.02 (dd, J = 8.4, 2.0 Hz, 1H, H-9), 7.20 (br d, J = 8.4 Hz, 1H, H-10), 7.27-7.37 (m, 3H, H-7 & H-
15), 7.56 (br s, 1H, H-11), 7.76 (d, J = 8.4 Hz, 2H, H-14); 13C NMR (100 MHz, HSQC, CDCl3): δ 
21.2 (C-12), 21.5 (C-17), 24.68 (C-2), 24.75 (CH3 iPr), 25.8 (C-6), 27.7 (C-1), 28.5 (C-5), 34.25 (CH 
iPr), 34.28 (C-11b), 40.5 (C-3), 49.1 (C-4a), 110.5 (C-10), 113.3 (C-6a), 115.3 (C-7), 120.5 (C-9), 
126.5 (C-6b), 127.0 (C-14), 129.7 (C-15), 134.8 (C-10a), 136.0 (C-8),138.5 (C-13), 140.2 (C-16), 
143.0 (C-11a); HRMS: m/z calcd for C26H33N2O2S (M + H)




A stirring solution of p-methoxyphenylhydrazine 
hydrochloride 1c (380 mg, 2.17 mmol), and solid acid catalyst 
Amberlite IR 120 H® (350 mg, 5 equiv w/w with respect to 3) 
in MeOH (2.1 mL, 0.1M) was mix for 5 minutes at 70 °C. On 
this mixture was added the 5-oxodecahydroquinoline 3 (70 
mg, 0.22 mmol). The mixture was left stirring at 70 °C for 24 h. 
After cooling, the reaction mixture was filtered and the resin 
was washed with CH2Cl2 and MeOH and the crude product was purified by chromatography 
(10-25-50% EtOAc/hexane) to afford 69 mg of a mixture 4c/7c in a ratio 33/67 (yield of 4c: 
24%). (NMR data of 4c were determined by removing signals of 7c). 
1H NMR (COSY, CDCl3, 400 MHz): δ 1.28-1.35 (m, 1H, H-5eq), 1.31 (d, J = 7.2  Hz, 3H, H-12), 
1.50-1.62 (m, 2H, H-1 and H-2), 1.62-1.70 (m, 1H, H-2), 1.92-2.00 (m, 1H, H-1), 2.31 (ddd, J = 
12.8, 12.8, 6.0 Hz, 1H, H-5ax), 2.44 (s, 3H, H-17), 2.80-2.88 (m, 1H, H-11b), 2.92-3.02 (m, 1H, H-
3ax), 3.12-3.20 (m, 1H, H-6), 3.83 (s, 3H, OMe), 3.95 (br d, J = 12.8 Hz, 1H, H-3eq), 4.55 (ddd, J 
= 13.2, 5.2, 2.8 Hz, 1H, H-4a), 6.78 (dd, J = 8.4, 2.4 Hz, 1H, H-9), 6.91 (d, J = 2.4 Hz, 1H, H-7), 
7.16 (d, J = 8.4 Hz, 1H, H-10), 7.31 (d, J = 8.0 Hz, 2H, H-15), 7.53 (br s, 1H, H-11), 7.75 (d, J = 8.4 
Hz, 2H, H-14); 13C NMR (100 MHz, HSQC, CDCl3): δ 21.0 (C-12), 21.5 (C-17), 24.7 (C-2), 25.8 (C-
6), 27.8 (C-1), 28.5 (C-5), 34.3 (C-11b), 40.5 (C-3), 49.1 (C-4a), 56.0 (OMe), 100.9 (C-7), 111.0 (C-
9), 111.4 (C-10), 113.4 (C-6a), 126.9 (C-6b), 127.0 (C-14), 129.7 (C-15), 131.3 (C-10a), 136.8 (C-
13),138.5 (C-16), 143.0 (C-11a), 153.9 (C-8); HRMS: m/z calcd for C24H29N2O3S (M + H)
+ 
425.1893, found 425.1881 
(4aRS,6RS,11bRS)-8-Fluoro-6-methyl-4-(4-methylphenylsulfonyl)-2,3,4,4a,5,6,11,11b-
octahydro-1H-pyrido[3,2-a]carbazole (4d) 
Following the general procedure B using p-fluorophenylhydrazine 
1d (392 mg, 3.11 mmol), 5-oxodecahydroquinoline 3 (100 mg, 
0.31 mmol) and Amberlite IR 120 H® (1.00 g) for 20 h, 4d was 
isolated after trituration in cold MeOH and recrystallization in 





Mp: 242-244 C; 1H NMR (COSY, CDCl3, 400 MHz):  δ 1.25-1.35 (m, 1H, H-5eq), 1.29 (d, J = 6.8  
Hz, 3H, H-12), 1.52-1.63 (m, 2H, H-1 and H-2), 1.63-1.73 (m, 1H, H-2), 1.92-2.02 (m, 1H, H-1), 
2.30 (ddd, J = 12.8, 12.8, 6.2 Hz, 1H, H-5ax), 2.45 (s, 3H, H-17), 2.87 (ddd, J = 11.6, 5.0, 5.0 Hz, 
1H, H-11b), 2.96 (br t, J = 12.8 Hz, 2H, H-3ax), 3.14 (br quint, J = 6.8 Hz, 1H, H-6), 3.94 (br d, J = 
12.8 Hz, 1H, H-3eq), 4.54 (ddd, J = 13.2,  5.2, 3.2 Hz, 1H, H-4a), 6.86 (ddd, J = 8.8, 8.8, 2.4,  Hz, 
1H, H-9), 7.09 (dd, J = 9.0, 2.4 Hz, 1H, H-7), 7.17 (dd, J = 8.8, 4.4 Hz, 1H, H-10), 7.31 (d, J = 8.4 
Hz, 1H, H-15), 7.64 (br s, 1H, H-11), 7.75 (d, J = 8.4 Hz, 2H, H-14); 13C NMR (100 MHz, HSQC, 
CDCl3): δ 21.0 (C-12), 21.5 (C-17), 24.7 (C-2), 25.7 (C-6), 27.7 (C-1), 28.3 (C-5), 34.3 (C-11b), 40.4 
(C-3), 49.0 (C-4a), 103.4 (d, J = 23.3 Hz, C-7), 109.5 (d, J = 26.1 Hz, C-9), 111.2 (d, J = 9.6 Hz, C-
10), 113.8 (C-6a), 126.9 (C-6b), 127.0 (C-14), 129.7 (C-15), 132.7 (C-10a), 137.8 (C-13), 138.4 (C-
16), 143.1 (C-11a), 157.7 (d, J = 234.4 Hz, C-8); HRMS: m/z calcd for C23H26FN2O2S (M + H)
+ 




Following the general procedure B using p-
trifluoromethylphenylhydrazine 1e (548 mg, 3.11 mmol), 5-
oxodecahydroquinoline 3 (100 mg, 0.31 mmol) and Amberlite 
IR 120 H® (1.00 g) for 72 h. Purification by chromatography 
(10-25-50% EtOAc/hexane) followed by trituration in cold 
MeOH allowed to obtain a mixture 4e/7e in a ratio 75/25 (yield 
of 4e: 8 mg, 5.5%). Another fraction was isolated 19 mg 
containing 50% of 4e/7e 1/2. The remaining part corresponding to hydrazone and 5-
oxodecahydroquinoline 3 (yield of 4e combined: 8%). (NMR data of 4e were determined by 
removing signals of 7e). 
1H NMR (COSY, CDCl3, 400 MHz):  δ 1.28-1.35 (m, 1H, H-5eq), 1.32 (d, J = 6.8  Hz, 3H, H-12), 
1.52-1.63 (m, 2H, H-1 & H-2), 1.66-1.73 (m, 1H, H-2), 1.95-2.05 (m, 1H, H-1), 2.31 (ddd, J = 
13.2, 13.2, 6.8 Hz, 1H, H-5ax), 2.45 (s, 3H, H-17), 2.89-3.08 (m, 2H, H-3ax & H-11b), 3.22 (quint, 
J = 6.8 Hz, 1H, H-6), 3.95 (br d, J = 12.4 Hz, 1H, H-3eq), 4.57 (ddd, J = 13.2,  5.2, 2.8 Hz, 1H, H-
4a), 7.28-7.38 (m, 4H, H-7, H-10 & H-15), 7.70-7.74 (m, 3H, H-9 & H-14), 7.89 (br s, 1H, H-11); 
13C NMR (100 MHz, HSQC, CDCl3): δ 21.3 (C-12), 21.5 (C-17), 24.7 (C-2), 25.6 (C-6), 27.7 (C-1), 
28.2 (C-5), 34.3 (C-11b), 40.4 (C-3), 48.9 (C-4a), 110.9 (C-7), 114.4 (C-6a), 115.9 (d, J = 4.1 Hz, C-
9), 118.3 (d, J = 3.4 Hz, C-10), 121.8 (q, J = 31.6 Hz, C-8), 125.3 (q, J = 269.6 Hz, C-18), 125.9 (C-
6b), 127.0 (C-14), 129.8 (C-15), 137.7 (C-13 & C-10a), 138.4 (C-16), 143.2 (C-11a);  HRMS: m/z 
calcd for C24H26F3N2O2S (M + H)





General procedure C: 
 
A stirring solution of phenylhydrazine hydrochloride 1·HCl (2.5 equiv), solid acid catalyst 
Amberlite IR 120 H® (10 equiv w/w with respect to 3) and 5-oxodecahydroquinoline 3 (1 equiv) 
in HCl/MeOH (1.25 M, 30 equiv) was stirred at 70 °C for the indicated time. After cooling, the 
reaction mixture was filtered and the resin was washed with CH2Cl2 and MeOH. The excess 
hydrazine salt was removed by precipitation in cold dichloromethane and the crude product 




Following the general procedure C using phenylhydrazine 
hydrochloride 1a·HCl (61 mg, 0.42 mmol), 5-oxodecahydroquinoline 3 
(54 mg, 0.17 mmol) and Amberlite IR 120 H® (500 mg) for 3 h, 7a was 
isolated as a pale yellow solid (62 mg, 92%) further crystallization 
from CHCl3 and DCE afforded pale yellow crystals.  
Mp: 205-207 C; 1H NMR (COSY, CDCl3, 400 MHz):  δ 1.41 (d, J = 6.8  
Hz, 3H, H-12), 1.45-1.52 (m, 1H, H-2), 1.60-1.72 (m, 2H, H-1 & H-2), 1.75-1.93 (m, 2H, H-5), 
1.95-2.02 (m, 1H, H-1), 2.44 (s, 3H, H-17), 2.78 (ddd, J = 12.0, 4.8, 4.8 Hz, 1H, H-11b), 3.05 (ddd, 
J = 13.4, 13.4, 2.4 Hz, 1H, H-3ax), 3.10-3.24 (m, 1H, H-6), 3.92 (br d, J = 13.4 Hz, 1H, H-3eq), 
4.36 (ddd, J = 12.8,  4.8, 3.6 Hz, 1H, H-4a), 7.05-7.15 (m, 2H, H-8 & H-9), 7.27 (d, J = 7.6  Hz, 1H, 
H-10), 7.30 (d, J = 8.4 Hz, 1H, H-15), 7.61 (d, J = 7.6 Hz,1H, H-7), 7.68 (br s, 1H, H-11), 7.75 (d, J 
= 8.4 Hz, 2H, H-14); 13C NMR (100 MHz, HSQC, CDCl3): δ 21.3 (C-12), 21.5 (C-17), 24.5 (C-2), 
28.14 (C-1), 28.32 (C-6), 32.3 (C-5), 34.0 (C-11b), 40.5 (C-3), 52.4 (C-4a), 110.7 (C-10), 113.1 (C-
6a), 119.3 (C-8), 119.9 (C-7), 121.3 (C-9), 126.6 (C-6b), 127.0 (C-14), 129.7 (C-15), 136.1 (C-10a), 






Following the general procedure C using p-
isopropylphenylhydrazine hydrochloride 1b·HCl (145 mg, 0.78 
mmol), 5-oxodecahydroquinoline 3 (100 mg, 0.31 mmol) and 
Amberlite IR 120 H® (1.00 g) for 3 h, 7b was isolated after 
trituration in cold MeOH and recrystallization in DCE as a white 





1H NMR (COSY, CDCl3, 400 MHz):  δ 1.29 (dd, J = 7.5, 1.6 Hz, 6H,2 x CH3 iPr), 1.40 (d, J = 6.8  Hz, 
3H, H-12), 1.43-1.53 (m, 1H, H-2), 1.53-1.68 (m, 2H, H-1 & H-2), 1.72-1.90 (m, 2H, H-5), 1.91-
1.99 (m, 1H, H-1), 2.42 (s, 3H, H-17), 2.74 (ddd, J = 12.0, 4.8, 4.8 Hz, 1H, H-11b), 2.91-3.15 (m, 
3H, CH iPr, H-3ax & H-6), 3.89 (br d, J = 13.6 Hz, 1H, H-3eq), 4.32 (ddd, J = 12.8,  4.8, 3.6 Hz, 1H, 
H-4a), 7.01 (bd, J = 8.4 Hz 1H, H-9), 7.18 (d, J = 8,4  Hz, 1H, H-10), 7.28 (d, J = 8.4 Hz, 2H, H-15), 
7.43 (bs, 1H, H-7), 7.66 (s, 1H, H-11), 7.73 (d, J = 8.4 Hz, 2H, H-14); 13C NMR (100 MHz, HSQC, 
CDCl3): δ 21.3 (C-12), 21.5 (C-17), 24.4 (C-2), 24.7 (CH3 iPr), 24.8 (CH3 iPr), 28.1 (C-1), 28.3 (C-6), 
32.3 (C-5), 34.0 (C-11b), 34. 3 (CH iPr), 40.5 (C-3), 52.5 (C-4a), 110.5 (C-10), 112.7 (C-6a), 116.9 
(C-7), 120.3 (C-9), 126.6 (C-6b), 126.8 (C-14), 129.7 (C-15), 134.9 (C-10a), 136.4 (C-8), 138.5 (C-
13), 139.9 (16), 143.0 (C-11a); HRMS: m/z calcd for C26H33N2O2S (M + H)





Following the general procedure C using p-
methoxyphenylhydrazine hydrochloride 1c·HCl (136 mg, 0.78 
mmol), 5-oxodecahydroquinoline 3 (100 mg, 0.31 mmol) and 
Amberlite IR 120 H® (1.00 g) for 6 h, 7c was isolated after 
purification by chromatography (10-25-50% EtOAc/hexane) 
followed by trituration in cold MeOH as a light pink solid (75 
mg, 57%). 
1H NMR (COSY, CDCl3, 400 MHz):  δ 1.40 (d, J = 6.8  Hz, 3H, H-12), 1.45-1.52 (m, 1H, H-2), 1.60-
1.72 (m, 2H, H-1 & H-2), 1.75-1.95 (m, 2H, H-5), 1.95-2.02 (m, 1H, H-1), 2.44 (s, 3H, H-17), 2.74 
(ddd, J = 12.0, 5.0, 5.0 Hz, 1H, H-11b), 3.05 (ddd, J = 13.6, 13.6, 2.4 Hz, 1H, H-3ax), 3.10-3.20 
(m, 1H, H-6), 3.84 (s, 3H, CH3O), 3.94 (br d, J = 13.6 Hz, 1H, H-3eq), 4.34 (ddd, J = 12.8,  5.0, 3.6 
Hz, 1H, H-4a), 6.79 (dd, J = 8.8, 2.4,  Hz, 1H, H-9), 7.07 (d, J = 2.4 Hz, 1H, H-7), 7.15 (d, J = 8.8 
Hz,1H, H-10), 7.29 (d, J = 8.4 Hz, 2H, H-15), 7.51 (br s, 1H, H-11), 7.74 (d, J = 8.4 Hz, 2H, H-14); 
13C NMR (100 MHz, HSQC, CDCl3): δ 21.2 (C-12), 21.5 (C-17), 24.4 (C-2), 28.15 (C-1), 28.24 (C-6), 
32.3 (C-5), 34.1 (C-11b), 40.5 (C-3), 52.4 (C-4a), 56.1 (CH3O), 102.8 (C-7), 110.8 (C-9), 111.2 (C-
10), 113.0 (C-6a),  126.96 (C-14), 127.01 (C-6b), 129.7 (C-15), 131.5 (C-10a), 137.1 (C-13), 138.6 
(C-16), 143.0 (C-11a), 153.7 (C-8); HRMS: m/z calcd for C24H29N2O3S (M + H)




Following the general procedure C using p-fluorophenylhydrazine 
hydrochloride 1d·HCl (127 mg, 0.78 mmol), 5-
oxodecahydroquinoline 3 (100 mg, 0.31 mmol) and Amberlite IR 
120 H® (1.00 g) for 3 h, 7d was isolated after trituration in cold 
MeOH and recrystallization in DCE as a white solid (101 mg, 82%). 
1H NMR (COSY, CDCl3, 400 MHz):  δ 1.37 (d, J = 6.4  Hz, 3H, H-12), 
1.46-1.53 (m, 1H, H-2), 1.58-1.72 (m, 2H, H-1 & H-2), 1.73-1.92 (m, 2H, H-5), 1.94-2.03 (m, 1H, 





Hz, 1H, H-3ax), 3.08-3.16 (m, 1H, H-6), 3.91 (ddd, J = 13.2, 2.4, 2.4 Hz, 1H, H-3eq), 4.34 (ddd, J = 
12.4,  5.0, 3.6 Hz, 1H, H-4a), 6.86 (ddd, J = 9.0, 9.0, 2.6 Hz, 1H, H-9), 7.16 (dd, J = 9.0, 4.4 Hz, 1H, 
H-10), 7.24 (dd, J = 9.6, 2.6 Hz, 1H, H-7), 7.30 (br d, J = 8.4 Hz,2H, H-15), 7.64 (s, 1H, H-11), 7.74 
(br d, J = 8.4 Hz, 2H, H-14); 13C NMR (100 MHz, HSQC, CDCl3): δ 21.0 (C-12), 21.5 (C-17), 24.5 
(C-2), 28.1 (C-1), 28.2 (C-6), 32.2 (C-5), 34.1 (C-11b), 40.5 (C-3), 52.3 (C-4a), 105.0 (d, J =23.9 Hz, 
C-7), 109.4 (d, J = 26.1 Hz, C-9), 111.1 (d, J = 9.9 Hz, C-10), 113.4 (C-6a), 126.9 (C-6b), 127.0 (C-
14), 129.7 (C-15), 132.8 (C-10a), 138.1 (C-13), 138.5 (C-16), 143.1 (C-11a), 157.5 (d, J = 233.8 
Hz, C-8); HRMS: m/z calcd for C23H26FN2O2S (M + H)




Following the general procedure C using p-
trifluoromethylphenylhydrazine hydrochloride 1e·HCl (166 mg, 
0.78 mmol), 5-oxodecahydroquinoline 3 (100 mg, 0.31 mmol) 
and Amberlite IR 120 H® (1.00 g) for 24 h, 7e was isolated after 
purification by chromatohraphy (10-25-50% EtOAc/hexane) 
followed by trituration in cold MeOH as a white solid (15 mg, 
10.5%) and the recovered filtrate 50 mg containing 15% of the 
product (Yield of 7e combined : 16%). 
1H NMR (COSY, CDCl3, 400 MHz):  δ 1.40 (d, J = 6.8  Hz, 3H, H-12), 1.47-1.53 (m, 1H, H-2), 1.62-
1.71 (m, 2H, H-1 & H-2), 1.72-1.92 (m, 2H, H-5), 1.97-2.07 (m, 1H, H-1), 2.44 (s, 3H, H-17), 2.84 
(ddd, J = 12.0, 4.8, 4.8 Hz, 1H, H-11b), 3.03 (ddd, J = 13.2, 13.2, 2.4 Hz, 1H, H-3ax), 3.12 (br 
quint, J = 6.8 Hz, 1H, H-6), 3.90 (br d, J = 13.2 Hz, 1H, H-3eq), 4.36 (ddd, J = 12.8, 4.8, 3.6 Hz, 
1H, H-4a), 7.28-7.38 (m, 4H, H-7, H-10 & H-15), 7.74 (d, J = 8.4 Hz, 2H, H-14), 7.86 (s, 1H, H-9), 
7.96 (s, 1H, H-11); 13C NMR (100 MHz, HSQC, CDCl3): δ 21.2 (C-12), 21.5 (C-17), 24.5 (C-2), 28.06 
(C-1), 28.13 (C-6), 31.9 (C-5), 34.1 (C-11b), 40.5 (C-3), 52.2 (C-4a), 110.8 (C-7), 114.0 (C-6a), 
117.3 (d, J = 4.2 Hz, C-9), 118.1 (d, J = 3.3 Hz, C-10), 121.6 (q, J = 31.6 Hz, C-8), 125.4 (q, J = 
269.8 Hz, C-18), 126.0 (C-6b), 126.9 (C-14), 129.8 (C-15), 137.8 (C-10a), 138.0 (C-13), 138.4 (C-
16), 143.2 (C-11a); HRMS: m/z calcd for C24H26F3N2O2S (M + H)






Synthesis of indoles in flow 
Cartridge assembly: 
Both ends of 10-cm Tefzel® (ETFE) tubing (1/8’’ 
OD, 1/16” ID, a) were blocked with cotton wool, 
fitted with assembled flat bottom super 
flangeless fittings + metal ferrules (1/8’’ OD, P-
359, IDEX, b) and male nut parts (LT-215, IDEX, 
c). These connections were mounted onto flat 
unions (P-703-01, IDEX, d). For the filling of the 
cartridges, only one end was blocked at first, the 
cartridge was filled with the catalyst (~100 mg) 
employing vacuum suction and after, the other end was blocked to 
seal the cartridge. 
Microreactor setup: 
All gas-tight syringes (5 mL, B-247, FutureChemistry Holding BV) were mounted on syringe 
pumps (B-230, FutureChemistry Holding BV) and connected to Tefzel® tubing (1/16’’ OD, 1529, 
IDEX) via female Luer adapters (P-628, IDEX). Throughout the flow system, all the tubing 
(Tefzel® 1/16’’ OD, 1529, IDEX) was assembled with super flangeless nut connections (P-287, 
IDEX) and assembled ferrules (P-259, IDEX) in order to achieve leak-free fluid connections. 
Also, a 5 bar back pressure regulator (B-444, FutureChemistry Holding BV) guaranteed 
pressurization inside the system before eluting into a collection flask (see Figure 1). 
 
Figure 1. Flow set-up including back pressure regulator (detail, right). 
Flow general procedure C: 
Two feed solutions were employed: stream A containing the ketone in solution, and stream B 
containing the hydrazine in solution both driven by syringe pumps (φA = φB). These were mixed 
in a PEEK T-mixer connection (P-713, IDEX) before entering the microreactor (consisting of a 
ETFE cartridge packed with Amberlite® IR 120 H) at 70 °C for 10 to 60 minutes. By removing 
the solvent in vacuo, the desired indole products were obtained. In some cases, further 
purification was achieved by recrystallization CH2Cl2 or methanol. 
Full characterization of the indole products can be found within the general procedure for the 










Calculation for reactions performed under flow conditions:  
For the reactions performed in flow, yields were calculated taking into account the total moles 
of product obtained (n(Collected Product)), the flow rate (φSM) and the concentration ([SM]) 
of the starting material and the overall collection time (t(Collection)), as shown in the equation 
below. 
           
                     
        
  
                
     
(4aRS,6RS,11bRS)-6-Methyl-4-(4-methylphenylsulfonyl)-2,3,4,4a,5,6,11,11b-octahydro-1H-
pyrido[3,2-a]carbazole (4a) 
Following the flow general procedure C using 5-
oxodecahydroquinoline 3 (0.05 M in MeOH/AcOH/DCE 4/2/4) and 
phenylhydrazine 1a (0.5 M in MeOH/AcOH 1/1) with reaction time = 
20 min, total flow = 15.00 μL·min-1 and collecting for 2 h (2 mL of 




Following the flow general procedure C using a 30 cm cartridge 
(inner volume 300 µL) 5-oxodecahydroquinoline 3 (0.05 M in 
MeOH/AcOH/DCE 4/2/4) and p-isopropylphenylhydrazine 
hydrochloride salt 1b·HCl (0.5 M in MeOH/AcOH 1/1) with 
reaction time = 30 min, total flow = 10.00 μL·min-1 and collecting 
for 2 h (2 mL of ketone), the crude 1H NMR spectrum showed 
full conversion to 4b which was isolated as a pale yellow solid 




Following the flow general procedure C using a 1 m cartridge 
(inner volume 1 mL), 5-oxodecahydroquinoline 3 (0.02 M in 
MeOH/AcOH/DCE 4/4/2) and p-methoxyphenylhydrazine 
hydrochloride salt 1c·HCl (0.2 M in MeOH) with reaction time 
= 60 min, total flow = 16.00 μL·min-1 and collecting for 2 h (2 
mL of ketone), the crude 1H NMR spectrum showed 55 % 
conversion to 4c with the remaining part corresponding to a 












Following the flow general procedure C using a 1 m cartridge 
(inner volume 1 mL), 5-oxodecahydroquinoline 3 (0.01 M in 
MeOH/AcOH/DCE 4/5/1) and p-fluorophenylhydrazine 
hydrochloride salt 1d·HCl (0.1 M in MeOH) with reaction time = 
60 min, total flow = 16.00 μL·min-1 and collecting for 2 h (2 mL of 
ketone), the crude 1H NMR spectrum showed 42% conversion to 




Following the flow general procedure C using a 1 m cartridge 
(inner volume 1 mL), 5-oxodecahydroquinoline 3 (0.04 M in 
AcOH/DCE 8/2) and p-trifluoromethylphenylhydrazine 1e (0.4 
M in MeOH) with reaction time = 60 min, total flow = 16.00 
μL·min-1 and collecting for 2 h (2 mL of ketone), the crude 1H 
NMR spectrum showed 22% conversion to 4e with the 



















































2.97 (ddd, 12.8, 
12.8, 2.8) 
2.91-3.05 (m) 2.92-3.02 (m) 2.96 (br t, 12.8) 2.89-3.08 (m) 
eq 3.95 (br d, 13.2) 3.94 (br d, 12.4) 3.95 (br d, 12.8) 3.94 (br d, 12.8) 3.95 (br d, 12.4) 
H-4a 
4.56 (ddd, 13.2, 
5.2, 3.2) 
4.56 (ddd, 13.2, 
5.0, 3.2) 
4.55 (ddd, 13.2, 
5.2, 2.8) 
4.54 (ddd, 13.2, 
5.2, 3.2) 




2.31 (ddd, 12.8, 
12.8, 6.0) 
2.30 (ddd, 13.2, 
13.2, 6.4) 
2.31 (ddd, 12.8, 
12.8, 6.0) 
2.30 (ddd, 12.8, 
12.8, 6.2) 
2.31 (ddd, 13.2, 
13.2, 6.8) 
eq 1.28-1.38 (m) 1.25-1.35 (m) 1.28-1.35 (m) 1.25-1.35 (m) 1.28-1.35 (m) 
H-6 3.21 (quint, 7.0) 3.20 (quint, 7.2) 3.12-3.20 (m) 3.14 (quint, 6.8) 3.22 (quint, 6.8) 
H-7 7.47 7.27-7.37 6.91 7.09 7.28-7.38 
H-8 7.05-7.15 --- --- --- --- 
H-9 7.05-7.15 7.02 6.78 6.86 7.70-7.74 
H-10 7.27 7.20 7.16 7.17 7.28-7.38 
H-11 7.66 7.56 7.53 7.64 7.89 
H-11b 
2.88 (ddd, 11.4, 
5.2, 5.2) 
2.85 (ddd, 11.6, 
5.0, 5.0) 
2.80-2.88 (m) 
2.87 (ddd, 11.6, 
5.0, 5.0) 
2.89-3.08 (m) 
Me 1.32 (d, 7.2) 1.33 1.31 1.29 1.32 
H-14 7.76 7.76 7.75 7.75 7.70-7.74 
H-15 7.31 7.27-7.37 7.31 7.31 7.28-7.38 















































3.05 (ddd, 13.4, 
13.4, 2.4) 
2.91-3.15 (m) 
3.05 (ddd, 13.6, 
13.6, 2.4) 
3.04 (ddd, 13.2, 
13.2, 2.4) 
3.03 (ddd, 13.2, 
13.2, 2.4) 
eq 3.92 (br d, 13.4) 3.89 (br d, 13.6) 3.94 (br d, 13.6) 3.91 (br d, 13.2) 3.90 (br d, 13.2) 
H-4a 
4.36 (ddd, 12.8, 
4.8, 3.6) 
4.32 (ddd, 12.8, 
4.8, 3.6) 
4.34 (ddd, 12.8, 
5.0, 3.6) 
4.34 (ddd, 12.4, 
5.0, 3.6) 
4.36 (ddd, 12.8, 
4.8, 3.6) 
H-5 1.75-1.93 (m) 1.72-1.90 (m) 1.75-1.95 (m) 1.73-1.92 (m) 1.72-1.92 (m) 
H-6 3.10-3.24 (m) 2.91-3.15 (m) 3.10-3.20 (m) 3.08-3.16 (m) 3.12 (quint, 6.8) 
H-7 7.61 7.43 7.07 7.24 7.28-7.38 
H-8 7.05-7.15 --- --- --- --- 
H-9 7.05-7.15 7.01 6.79 6.86 7.86 
H-10 7.27 7.18 7.15 7.16 7.28-7.38 
H-11 7.68 7.66 7.51 7.64 7.96 
H-11b 
2.78 (ddd, 12.0, 
4.8, 4.8) 
2.74 (ddd, 12.0, 
4.8, 4.8) 
2.74 (ddd, 12.0, 
5.0, 5.0) 
2.78 (ddd, 12.0, 
5.0, 5.0) 
2.84 (ddd, 12.0, 
4.8, 4.8) 
Me 1.41 (d, 6.8) 1.40 (d, 6.8) 1.40 (d, 6.8) 1.37 (d, 6.4) 1.40 (d, 6.8) 
H-14 7.75 7.73 7.74 7.74 7.74 
H-15 7.30 7.28 7.29 7.30 7.28-7.38 




























C-1 27.7 27.7 27.8 27.7 27.7 
C-2 24.7 24.7 24.7 24.7 24.7 
C-3 40.5 40.5 40.5 40.4 40.5 
C-4a 49.1 49.1 49.1 49.0 48.9 
C-5 28.4 28.5 28.5 28.3 28.2 
C-6 25.8 25.8 25.8 25.7 25.6 
C-6a 113.5 113.3 113.4 113.8 114.4 
C-6b 126.5 126.5 126.9 126.9 125.9 
C-7 118.3 115.3 100.9 103.4 110.9 
C-8 119.3 136.0 153.9 157.7 121.6 
C-9 121.5 120.5 111.0 109.5 115.9 
C-10 110.7 110.5 111.4 111.2 118.3 
C-10a 135.8 134.8 131.3 132.7 137.7 
C-11a 143.1 143.0 143.0 143.1 143.2 
C-11b 34.2 34.3 34.3 34.3 34.3 
Me 21.2 21.2 21.0 21.0 21.3 
Me-Ts 21.5 21.5 21.5 21.5 21.6 
C-13 136.2 138.5 136.8 137.8 137.8 
C-14 127.0 127.0 127.0 127.0 127.0 
C-15 129.7 129.7 129.7 129.7 129.8 
C-16 138.5 140.2 138.5 138.4 138.4 
Other  
24.8 & 34.3 
(iPr) 























C-1 28.1 28.1 28.2 28.1 28.1 
C-2 24.5 24.4 24.4 24.5 24.5 
C-3 40.5 40.5 40.5 40.5 40.5 
C-4a 52.4 52.5 52.4 52.3 52.2 
C-5 32.3 32.3 32.3 32.2 31.9 
C-6 28.3 28.3 28.2 28.2 28.1 
C-6a 113.1 112.7 113.0 113.4 114.0 
C-6b 126.6 126.6 127.01 126.9 126.0 
C-7 119.9 116.9 102.8 105.0 110.8 
C-8 119.3 136.4 153.7 157.5 121.6 
C-9 121.3 120.3 110.8 109.4 117.3 
C-10 110.7 110.5 111.2 111.1 118.1 
C-10a 136.1 134.9 131.5 132.8 137.8 
C-11a 143.1 143.0 143.0 143.1 143.2 
C-11b 34.0 34.0 34.1 34.1 34.1 
Me 21.3 21.3 21.2 21.0 21.2 
Me-Ts 21.5 21.5 21.5 21.5 21.5 
C-13 136.3 138.5 137.1 138.1 138.0 
C-14 127.0 126.8 126.96 127.0 126.9 
C-15 129.7 129.7 129.7 129.7 129.8 
C-16 138.5 139.9 138.6 138.5 138.4 
Other  
24.7 & 34.3 
(iPr) 








































































































































X-Ray Crystallographic Data 
X-Ray crystallographic Data for compound 4a 
CCDC 1476675 contain the supplementary crystallographic data for this paper. These data can 
be obtained free of charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif 
 
Table 3.  Crystal data and structure refinement for 4a. 
Identification code  p1585c 
Empirical formula  C23 H26 N2 O2 S 
Formula weight  394.52 
Temperature  208 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/c (No. 14) 
Unit cell dimensions a = 14.776(3) Å = 90°. 
 b = 9.354(2) Å = 94.17(3)°. 
 c =14.360(3) Å  = 90°. 
Volume 1979.5(7) Å3 
Z 4 
Density (calculated) 1.324 Mg/m3 
Absorption coefficient 0.185 mm-1 
F(000) 840 
Crystal size 0.07 x 0.25 x 0.53 mm3 





Table 4.  Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for p1585c. Parameters of the non-Hydrogen atoms for: p1585c    P 21/c       R = 0.05           
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
S001                                       0.40290(3)           0.77954(6)           0.57944(3)               0.0259(1)    
O002                                      0.48372(8)          0.86539(16)          0.59223(9)               0.0326(4)              
O003                                      0.38857(9)          0.66776(15)          0.64496(8)               0.0318(4)              
N004     0.33093(11)  0.24063(19)   0.33126(11)            0.0282(5)              
N005    0.40455(10)  0.70656(17)   0.47755(10)          0.0250(5)              
C006         0.31249(12)        0.3774(2)     0.36039(12)                0.0245(6)              
C007       0.17961(12)        0.2719(2)     0.31596(12)           0.0265(6)              
C008      0.38393(11)      0.4809(2)   0.39469(12)          0.0225(6)              
C009       0.22112(12)       0.4012(2)   0.35133(12)          0.0261(6)              
C00A    0.33633(11)    0.5964(2)   0.44869(12)          0.0240(6)              
C00B    0.30839(12)    0.8933(2)   0.57866(12)          0.0245(6)              
C00C    0.25294(12)    0.6550(2)   0.39099(13)          0.0283(6)              
C00D     0.44791(13)     0.7774(2)   0.40104(13)          0.0297(6)              
C00E        0.43421(12)    0.5454(2)   0.31441(12)          0.0289(6)              
C00F    0.31183(14)    1.0302(2)   0.54148(13)          0.0339(7)              
C00G    0.17858(12)       0.5410(2)     0.37577(14)              0.0309(6)              
C00H         0.49788(12)        0.6652(2)     0.34870(13)              0.0308(6)              
C00I         0.15359(14)        1.0631(3)     0.56712(13)              0.0348(7)              
C00J        0.09007(13)     0.2272(2)    0.29436(13)              0.0339(7)              
C00K     0.22838(13)     0.8419(2)    0.61037(13)                0.0332(7)              
C00L        0.23504(15)     1.1133(2)     0.53682(14)                0.0388(7)              
C00M       0.25027(13)     0.1735(2)    0.30409(13)                0.0279(6)              
C00N         0.23431(14)     0.0357(2)    0.27137(14)                0.0372(7)              
C00O         0.15184(14)     0.9269(3)   0.60395(13)                0.0370(7)              
C00P        0.07417(14)     0.0894(3)     0.26361(15)              0.0405(7)              
C00Q         0.14492(14)    -0.0050(3)     0.25177(14)              0.0419(8)                         
C00R      0.12054(14)     0.5294(3)     0.45857(16)              0.0467(8)              
C00S         0.06945(15)      1.1552(3)     0.55820(16)             0.0512(9)              
 
